DexCom, Inc. (DXCM) Q2 2014 Earnings Results

Dexcom Misses on Revenue, Stock Down 2.28%

Dexcom's earnings report shows a slight miss on revenue expectations, although the EPS beat was a positive sign. The stock reacted negatively, dropping 2.28%, likely due to the lack of revenue details and guidance. Investors may be cautious as the company navigates its growth strategy amidst current market conditions.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$-0.09	N/A	+5.26%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Management remains focused on innovation and market expansion. They acknowledged the current hurdles but are optimistic about future opportunities.

Management highlighted ongoing investments in product development.

They expressed confidence in long-term growth despite current challenges.

Dexcom Misses on Revenue, Stock Down 2.28%

Key numbers

Management commentary

DexCom, Inc.

More earnings this week

Dexcom Misses on Revenue, Stock Down 2.28%

Key numbers

Management commentary